Ipratropium Pregnancy and Breastfeeding Warnings
Ipratropium is also known as: Atrovent, Atrovent HFA, Ipratropium Inhalation Aerosol, Ipratropium Inhalation Solution
Ipratropium Pregnancy Warnings
Ipratropium has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of teratogenicity. However, there are no controlled data in human pregnancy. Ipratropium is recommended for use during pregnancy when benefit outweighs risk.
One malformation, a renal obstruction, occurred between 1982 and 1994 among 37 women who took this drug during the first trimester according to data taken from a study of Medicaid patients.
Ipratropium Breastfeeding Warnings
There are no data on the excretion of ipratropium into human milk. Due to low serum concentrations obtained with oral inhalation and intranasal administration, as well as poor absorption of ipratropium from the gastrointestinal tract, it is unlikely that the drug would reach a nursing infant in an appreciable amount. The manufacturer recommends that caution be used when administering ipratropium to nursing women.
See Also...
- Ipratropium use while Breastfeeding (in more detail)
- ipratropium aerosol suspension Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
